Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 27 recruiting now early-phase tilt

Obesity and Overweight: early-phase trial registry

27 of 28 indexed Obesity and Overweight trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #577 of 28,707 conditions by registered trial count.

28 US clinical trials · 27 currently recruiting · #577 of 28,707 conditions by registered trial count

Obesity and Overweight: 28 US clinical trials tracked, 27 recruiting.

Obesity and Overweight is the subject of 28 registered US clinical trials on ClinicalTrials.gov, 27 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 6 in Phase 1-2 (earlier-stage). The most active sponsor is Dr. Christopher McGowan, running 2 of these trials.

Enrollment posture brief

Registry condition obesity-and-overweight

OPEN 27 | RECR 96% | LATE 1 | EARLY 6 | RANK #577 | SPON 2

Nearest open-share peer: Depression - Major Depressive Disorder (95% recruiting · 20 trials)

Obesity and Overweight (this)96%Anatomic Stage IB Breast Can25%Carcinoma, Hepatocellular25%Autistic Disorder17.9%Cocaine-Related Disorders0%
Open-enrollment share among volume-matched conditions near Obesity and Overweight

Obesity and Overweight lists 27 open slots (96% of 28 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Obesity and Overweight on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Obesity and Overweight is recruiting above its size-band peers.

    27 of 28 indexed trials (96.4%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. Sponsorship of Obesity and Overweight trials is spread across many organizations.

    Dr. Christopher McGowan accounts for 2 of 28 trials (7.1%). 24 distinct sponsors appear on at least one study for this condition label.

  3. Most Obesity and Overweight trials plan to enrol fewer than 100 people.

    Median target enrolment is 55 among the 28 trials that report a genuine target (sentinel values excluded). 17 of those (60.7%) plan for fewer than 100 participants.

  4. Obesity and Overweight research is mostly interventional.

    25 interventional and 3 observational studies make up this index (89.3% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 12Phase 24Phase 31

Open and recent trials

28 total, page 1 of 1

RECRUITING NA 6,200 participants

Advancing Biopsychosocial Care Training Initiative

Washington University School of Medicine

NCT07049861

RECRUITING Phase 3 3,500 participants

Efficacy and Safety of MET097 Once-Weekly in People With Overweight or Obesity

Metsera, a wholly owned subsidiary of Pfizer

NCT07311850

RECRUITING NA 795 participants

CHIME: Comparing Health Interventions for Maternal Equity

Stanford University

NCT06724172

RECRUITING NA 290 participants

Comparision of Aerobic Exercise to Aerobic Plus Yoga Exercise for Weight Loss in Adults With Overweight or Obesity.

University of Kansas Medical Center

NCT06636773

RECRUITING NA 256 participants

FAMily-centered WEight Loss for Black Adults (FAM WEL B-ing)

University of North Carolina, Chapel Hill

NCT06724406

RECRUITING 210 participants

Brain and Behavior Influences on Obesity Development From Infancy Through Childhood

Johns Hopkins University

NCT06861868

RECRUITING Phase 2 200 participants

A Mobile Intervention to Reduce Pain and Improve Health-III

Wake Forest University

NCT06623669

RECRUITING Phase 1 136 participants

A Phase 1 Study of WVE-007 in Adults Living With Overweight or Obesity

Wave Life Sciences

NCT06842186

RECRUITING Phase 2 105 participants

Efficacy and Safety of Tirzepatide Versus Placebo or Lisdexamfetamine Dimesylate for Binge-Eating Disorder

Johns Hopkins University

NCT06847399

RECRUITING 100 participants

Study of Patients Being Treated With Anti-obesity Medication

Texas Tech University

NCT06790160

RECRUITING NA 80 participants

A Study to Evaluate a Postbiotic in Supporting Weight Loss and Metabolic Health

ResBiotic Nutrition

NCT06911073

RECRUITING NA 60 participants

Weight Management Intervention in College: A Pilot

The Miriam Hospital

NCT06994923

RECRUITING NA 55 participants

New Mechanisms of Obesity

Yale University

NCT06768827

RECRUITING NA 50 participants

To Test Whether Time-restricted Eating Coupled With a Healthy Diet is Beneficial in Liver Cancer Patients

University of California, San Diego

NCT06824974

RECRUITING 50 participants

Mitigation of Cardiovascular Disease Risks in Children With Extreme Obesity

John Bauer

NCT06967389

RECRUITING NA 48 participants

FRESH-EATS Project

University of South Florida

NCT07053644

RECRUITING NA 44 participants

Metabolic Health, Bones and Nuts During Weight Loss in Adults

Rutgers, The State University of New Jersey

NCT06949280

RECRUITING Phase 2 42 participants

Tirzepatide for Alcohol Use Disorder

University of Southern California

NCT06994338

RECRUITING NA 40 participants

Muscle and Movement With Anti-Obesity Medications

University of Kansas Medical Center

NCT06645470

RECRUITING NA 38 participants

BrainWeighve App Feasibility Study

University of California, Los Angeles

NCT05530538

RECRUITING NA 36 participants

Effect of Watermelon on Gut and Cardiometabolic Health

Florida State University

NCT06588218

RECRUITING NA 30 participants

Development of an Inclusive Adaptive Treatment Strategy for Weight Loss in People With Prediabetes Using a Sequential Multiple Assignment Randomized Trial

University of Alabama at Birmingham

NCT06976307

RECRUITING NA 24 participants

Metabotyping of Broccoli Microgreen in Obese Breast Cancer Survivors

University of Maryland, Baltimore

NCT07032545

RECRUITING NA 20 participants

MAINTAIN (Mucosal AblatIoN Therapy After INcretins)

Dr. Christopher McGowan

NCT06734312

RECRUITING NA 20 participants

Effects of Ultra Processed Food on Intestinal Energy Harvest

Columbia University

NCT06853288

RECRUITING Phase 2 12 participants

Effects of Tirzepatide on Weight Loss and Chronic Inflammation in People With HIV

University of Hawaii

NCT06935838

RECRUITING NA 5 participants

REvision of VSG with Ablation of the Mucosa Procedure

Dr. Christopher McGowan

NCT06671119

ACTIVE NOT RECRUITING Phase 1 120 participants

A Study of MET233 in Individuals With Obesity or Overweight

Metsera, a wholly owned subsidiary of Pfizer

NCT07022977

Phase Distribution

PhaseTrial count
Phase 1 2
Phase 2 4
Phase 3 1

Named interventions

Most-linked intervention names on Obesity and Overweight records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Tirzepatide Drug
3 trials
MET233 Biological
1 trials
Postbiotic Dietary supplement
1 trials
Community-Based Behavioral
1 trials
Self-Management Behavioral
1 trials
Lagged Intervention Control Group Behavioral
1 trials
FRESH-EATS Behavioral
1 trials
Diet containing 20% ultra processed foods Behavioral
1 trials

US sites by state

Facility locations filed on Obesity and Overweight trials. A trial with sites in several states counts in each.

California 6 trials
North Carolina 5 trials
Maryland 4 trials
Florida 3 trials
Rhode Island 2 trials
New York 2 trials
Kansas 2 trials
Alabama 2 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Obesity and Overweight page

28 registered trials, 27 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Obesity and Overweight condition card totals 28 registered trials; most-linked intervention Tirzepatide; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.